Literature DB >> 192753

Reactivity of non-primate growth hormones and prolactins with human growth hormone receptors on cultured human lymphocytes.

M A Lesniak, P Gorden, J Roth.   

Abstract

Ovine placental lactogen is as reactive as human growth hormone with the human growth hormone receptor of cultured human (IM-9) lymphocytes, which confirms the findings of Carr and Friesen with receptors of human liver. We now also show that bovine and ovine growth hormones and ovine prolactin have reactivity for the human growth hormone receptor on IM-9 lymphocytes that is of the same order of magnitude (0.03%) as that previously reported for human placental lactogen. The binding studies predict that these non-primate hormones will have biological effects on skeletal growth in primates, either as agonists or antagonists. Previous studies have shown that when IM-9 lymphocytes are exposed to human growth hormone for 18 h at 37 C, there is a time and concentration dependent loss of human growth hormone receptors, and the magnitude of the loss of receptors after preincubation for 18 h at 37 C is greater than the average occupancy of receptors under steady state conditions for 90 min at 30 C. In the present study we show that human and ovine placental lactogens, ovine prolactin, and bovine and ovine growth hormones also produce this effect on the human growth hormone receptor. Since the cellular process by which a hormone induces loss of its own receptors appears to require binding of the hormone to its receptor as well as one or more subsequent steps in hormone action, it is likely that all of the preparations that induce receptor loss will be shown to have some agonist activity of human growth hormone in promoting skeletal growth in primates. Further, these studies extend the interrelationships between primate and non-primate pituitary and placental hormones from what has been suggested previously from biological and structural studies.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 192753     DOI: 10.1210/jcem-44-5-838

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

1.  The human growth hormone receptor of cultured human lymphocytes. Structural characteristics and glycosylation properties.

Authors:  K Asakawa; J A Hedo; A McElduff; D G Rouiller; M J Waters; P Gorden
Journal:  Biochem J       Date:  1986-09-01       Impact factor: 3.857

2.  Receptor-binding and down-regulatory properties of 22000-Mr human growth hormone and its natural 20000-Mr variant on IM-9 human lymphocytes.

Authors:  J Smal; J Closset; G Hennen; P de Meyts
Journal:  Biochem J       Date:  1985-01-15       Impact factor: 3.857

3.  Evaluation of growth hormone bioactivity using the Nb2 cell bioassay in children with growth disorders.

Authors:  M Bozzola; M Zecca; F Locatelli; G Radetti; S Pagani; M Autelli; L Tatò; P Chatelain
Journal:  J Endocrinol Invest       Date:  1998-12       Impact factor: 4.256

4.  Determination and properties of proteohormone receptors in malignant gynecological tumors with special reference to lactogen receptors in human breast cancer.

Authors:  H G Bohnet
Journal:  Arch Gynecol       Date:  1980

5.  Absence of serum growth hormone binding protein in patients with growth hormone receptor deficiency (Laron dwarfism).

Authors:  W H Daughaday; B Trivedi
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

6.  Cardiomegaly and heart failure in a patient with prolactin-secreting pituitary tumour.

Authors:  G Curtarelli; C Ferrari
Journal:  Thorax       Date:  1979-06       Impact factor: 9.139

7.  Purification of a distinct placental lactogen receptor, a new member of the growth hormone/prolactin receptor family.

Authors:  M Freemark; M Comer
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

8.  Influence of serotonin on the immune response.

Authors:  J C Jackson; R J Cross; R F Walker; W R Markesbery; W H Brooks; T L Roszman
Journal:  Immunology       Date:  1985-03       Impact factor: 7.397

9.  Hormonal control of immunoreactive somatomedin production by cultured human fibroblasts.

Authors:  D R Clemmons; L E Underwood; J J Van Wyk
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

10.  A single arginine residue determines species specificity of the human growth hormone receptor.

Authors:  S C Souza; G P Frick; X Wang; J J Kopchick; R B Lobo; H M Goodman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.